The Health Department is offering a grant to accelerate the development of devices aimed at treating Substance Use Disorders. This opportunity aims to leverage technological advancements to create safe and effective neuromodulatory or neurophysiological devices for treating SUDs. The goal is to progress these devices to the next stage of FDA approval, ultimately leading to the creation of new FDA-approved device-based treatments for Substance Use Disorders. Closing date for application submission is July 24, 2020, 12:00 AM EDT.
Opportunity ID: 299447
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-494 |
Funding Opportunity Title: | Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 15, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jul 24, 2020 |
Current Closing Date for Applications: | Jul 24, 2020 |
Archive Date: | Aug 29, 2020 |
Estimated Total Program Funding: | – |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Private institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities to develop neuromodulatory or neurophysiological devices that are safe and effective SUD treatments. The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-494.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237073 | Feb 27, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260432 | Feb 27, 2018 | Jul 24, 2020 | View |
Package 1
Mandatory forms
299447 RR_SF424_2_0-2.0.pdf
299447 PHS398_CoverPageSupplement_4_0-4.0.pdf
299447 RR_OtherProjectInfo_1_4-1.4.pdf
299447 PerformanceSite_2_0-2.0.pdf
299447 RR_KeyPersonExpanded_2_0-2.0.pdf
299447 RR_Budget_1_4-1.4.pdf
299447 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299447 RR_SubawardBudget30_1_4-1.4.pdf
299447 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299447 RR_SF424_2_0-2.0.pdf
299447 PHS398_CoverPageSupplement_5_0-5.0.pdf
299447 RR_OtherProjectInfo_1_4-1.4.pdf
299447 PerformanceSite_2_0-2.0.pdf
299447 RR_KeyPersonExpanded_2_0-2.0.pdf
299447 RR_Budget_1_4-1.4.pdf
299447 PHS398_ResearchPlan_4_0-4.0.pdf
299447 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299447 RR_SubawardBudget30_1_4-1.4.pdf
299447 PHS_AssignmentRequestForm_3_0-3.0.pdf